Essex Woodlands Management as of June 30, 2021
Portfolio Holdings for Essex Woodlands Management
Essex Woodlands Management holds 9 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| MiMedx (MDXG) | 43.2 | $292M | 23M | 12.51 | |
| Bioventus Com Cl A (BVS) | 31.4 | $213M | 12M | 17.60 | |
| Venus Concept | 5.7 | $39M | 12M | 3.11 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 5.6 | $38M | 4.2M | 8.99 | |
| Revance Therapeutics (RVNC) | 5.5 | $37M | 1.3M | 27.95 | |
| Axogen (AXGN) | 4.1 | $28M | 1.3M | 21.61 | |
| Tela Bio (TELA) | 3.8 | $26M | 1.6M | 16.11 | |
| Medicinova Com New (MNOV) | 0.7 | $4.7M | 1.1M | 4.25 | |
| Catalyst Biosciences Com New | 0.1 | $340k | 79k | 4.32 |
